We previously reported that, in patients with bone metastases from breast cancer, a high number of metastatic vertebrae (≥20) and elevated carcinoembryonic antigen (CEA) levels (≥5 ng/mL) were significant risk factors for SREs [14]. This evidence concerns the gene CEACAM5 and breast carcinoma.